Optomed Oyj (OPTOMED.HE)
EUR 3.95
(3.27%)
EUR 3.95
(3.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.71 Million EUR | -20.44% |
| 2022 | 10.95 Million EUR | -8.27% |
| 2021 | 11.94 Million EUR | 8.6% |
| 2020 | 11 Million EUR | -35.19% |
| 2019 | 16.97 Million EUR | 8.84% |
| 2018 | 15.59 Million EUR | 78.06% |
| 2017 | 8.75 Million EUR | 34.62% |
| 2016 | 6.5 Million EUR | 12.68% |
| 2015 | 5.77 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 8.45 Million EUR | -3.02% |
| 2024 Q2 | 8.33 Million EUR | -1.4% |
| 2023 Q3 | 9.79 Million EUR | -6.04% |
| 2023 Q4 | 8.71 Million EUR | -10.98% |
| 2023 Q1 | 10.52 Million EUR | -3.95% |
| 2023 Q2 | 10.42 Million EUR | -0.97% |
| 2023 FY | 8.71 Million EUR | -20.44% |
| 2022 Q4 | 10.95 Million EUR | 7.25% |
| 2022 Q2 | 11.83 Million EUR | 3.8% |
| 2022 FY | 10.95 Million EUR | -8.27% |
| 2022 Q3 | 10.21 Million EUR | -13.66% |
| 2022 Q1 | 11.4 Million EUR | -4.57% |
| 2021 Q4 | 11.94 Million EUR | 6.58% |
| 2021 FY | 11.94 Million EUR | 8.6% |
| 2021 Q3 | 11.2 Million EUR | 6.57% |
| 2021 Q1 | 11.03 Million EUR | 0.3% |
| 2021 Q2 | 10.51 Million EUR | -4.68% |
| 2020 FY | 11 Million EUR | -35.19% |
| 2020 Q2 | 10.67 Million EUR | -3.8% |
| 2020 Q3 | 10.34 Million EUR | -3.09% |
| 2020 Q4 | 11 Million EUR | 6.35% |
| 2020 Q1 | 11.09 Million EUR | -34.63% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 FY | 16.97 Million EUR | 8.84% |
| 2019 Q4 | 16.97 Million EUR | 8.18% |
| 2019 Q3 | 15.68 Million EUR | 0.0% |
| 2018 Q4 | 15.59 Million EUR | 0.0% |
| 2018 FY | 15.59 Million EUR | 78.06% |
| 2017 FY | 8.75 Million EUR | 34.62% |
| 2016 FY | 6.5 Million EUR | 12.68% |
| 2015 FY | 5.77 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|